The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials

Published:2022-02-07 Issue:5 Volume:94 Page:2222-2229
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Lin Wei‐Ting¹,Hung Shun‐Hsing²,Lai Chih‐Cheng³^ORCID,Wang Cheng‐Yi⁴,Chen Chao‐Hsien⁵⁶^ORCID

Affiliation:

1. Department of Orthopedic Chi Mei Medical Center Tainan Taiwan

2. Department of Surgery, Division of Urology Chi‐Mei Hospital, Chia Li Tainan Taiwan

3. Department of Internal Medicine Kaohsiung Veterans General Hospital, Tainan Branch Tainan Taiwan

4. Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine Fu Jen Catholic University New Taipei City Taiwan

5. Department of Internal Medicine, Division of Pulmonary MacKay Memorial Hospital Taipei Taiwan

6. Department of Medicine MacKay Medical College New Taipei City Taiwan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27623

Reference34 articles.

1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

2. World Health Organization. WHO coronavirus (COVID‐19) dashboard; 2021. Accessed July 15 2021. https://covid19whoint/

3. COVID-19 vaccines: concerns beyond protective efficacy and safety